Contract Research

Companies Contract Research

News Contract Research

• Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging

  Molecular Imaging, Inc., a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, announced that it has entered into a licensing agreement with Dana-Farber Cancer Institute to access a substantial number o more

• GVK Biosciences presented the Frost & Sullivan Growth Leadership Award in Contract Research Service Market

  GVK Biosciences (GVK BIO) announced that it was awarded the Frost & Sullivan 2011 Best Practices Award for Growth Leadership in the Contract Research Services Market. The Frost & Sullivan Award for Growth Leadership is presented to the company that has demonstrated excellence in capturing an impress more

• Spinnovation launch new biologics division with unique service provision

  Frederic Girard, CEO Spinnovation Analytical BV announced the launch of a new division of the company – Spinnovation Biologics – at the annual meeting of the Flanders Biotech group. Extending the company’s current contract research and contract analysis services, the new division will provide a uniq more

White papers Contract Research

• Outsourcing in Clinical Research - The Indian Perspective
  

  New pharmaceutical strategies pursue increased Research and Development (R&D) investments ranging 15-20% in contrast to late 80's period where classical model across was 10%. The annual budget allocation spent with clinical research organizations (CRO) is approximately $12 billion in an attempt to increase throughput, which has predominantly benefited CRO's who have seen their turnover boost growth of 20-30% year on year. more

• Outsourcing R&D Innovation takes on New Meaning
  

  Innovative drugs are the lifeblood of pharmaceutical companies, but the cost of developing them is rising to unsustainable levels. Pharma executives are already saying that as the economy falters, they foresee bleak prospects and mergers unless their companies get more innovative drugs into their pipelines. The clock is ticking on the race to increase productivity, as key patents worth a projected $30 billion in revenue will expire between 2010 and 2013, opening the floodgates to competition from generics, according to Barbara Ryan, an analyst at Deutsche Bank. This imperative is propelling increased outsourcing of R&D operations as companies trim overcapacity. more

• Outsourcing in Pharmaceutical Industry

  Pharmaceutical industry is constantly undergoing a change. In the past pharmaceuticals had a different strategy, companies use to build all the products internally and confine access to information or resources to third parties. The past situation is changing; in-house resources are getting exhausted with a very thin product pipeline and in addition many drugs are going off patent by 2008 hampering company sales and competitiveness. It takes $800 million and 20 years for... more

Publications Contract Research

• Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy volunteers: headache, back pain, tolerability and measured acetylcholine profile

  Background/aim Timed interval cerebrospinal fluid (CSF) sampling by indwelling catheterization can be a valuable corroborative tool for the pharmacokinetic and pharmacodynamic assessment of drugs. CSF sampling in studies on drug candidates for Alzheimer’s disease have been conducted in evaluations o more

• United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study

  by Jill A. Fisher, Corey A. Kalbaugh Background There have been dramatic increases over the past 20 years in the number of nonacademic, private-sector physicians who serve as principal investigators on US clinical trials sponsored by the pharmaceutical industry. However, there has been little res more

• United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study

  by Jill A. Fisher, Corey A. Kalbaugh Background There have been dramatic increases over the past 20 years in the number of nonacademic, private-sector physicians who serve as principal investigators on US clinical trials sponsored by the pharmaceutical industry. However, there has been little res more

Market studies Contract Research

• Contract Research Organization Market in the US 2011-2015

  TechNavio's analysts forecast the Contract Research Organization market in the US to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing outsourcing of R&D activities. The Contract Research Organization market in the US more

• Global Contract Research Organization Market 2011-2015

  TechNavio's analysts forecast the Global Contract Research Organization (CRO) market to grow at a CAGR of 10.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in outsourcing of R&D activities. The Global Contract Research Organization mark more

• Axiogenesis AG - Strategic SWOT Analysis Review

  Axiogenesis AG (Axiogenesis) is an innovative biotechnology company that specializes in applied stem cell technology and molecular and cellular biology. The company is mainly engaged in the development of novel assays that use differentiated embryonic stem cell (ESC)-derived cells that display norma more

Websites Contract Research